From Nasdaq:

Shares of Quantum-Si (NASDAQ: QSI) saw a wild 2023, with a significant increase in July when Cathie Wood started buying the stock again. Medical giant Thermo Fisher Scientific is acquiring Olink for $3.1 billion, showing the promise of proteomics technology. While Quantum-Si has shown signs of life, it’s at a financial disadvantage for now. It logged only $223,000 in sales in Q3 2023. Thermo Fisher, on the other hand, is highly profitable, making it a more surefire long-term investment than Quantum-Si. However, for more speculative investors, Quantum-Si holds promise.



Read more: Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment